Spire Healthcare Group (LON:SPI) Trading Up 13.4% - Should You Buy?

Key Points

• Spire Healthcare Group's stock price surged by 13.4%, closing at GBX 245.50, with a substantial trading volume of approximately 40.97 million shares.
• Three investment analysts have rated Spire Healthcare with a Buy rating, indicating positive investor sentiment and an average target price of GBX 294.33.
• The company reported earnings per share (EPS) of GBX 4.10 for the last quarter, with analysts projecting EPS of approximately 15.66 for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shot up 13.4% on Friday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 245.50 ($3.32). 40,970,105 shares were traded during mid-day trading, an increase of 2,397% from the average session volume of 1,640,628 shares. The stock had previously closed at GBX 216.50 ($2.93).

Wall Street Analysts Forecast Growth

SPI has been the topic of several research reports. Berenberg Bank reissued a "buy" rating and set a GBX 280 price objective on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. reduced their target price on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of GBX 294.33.

Spire Healthcare Group Stock Performance

The company has a market capitalization of £981.79 million, a price-to-earnings ratio of 5,304.35, a PEG ratio of 1.06 and a beta of 0.96. The stock has a fifty day moving average price of GBX 218.99 and a two-hundred day moving average price of GBX 203.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.